Showing results (61-70 of 166) with videos related to

Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2024
CNS Protective Effect of Selpercatinib in First-Line <i>RET</i> Fusion-Positive Advanced Non-Small Cell Lung CancerMaurice Pérol, Benjamin J Solomon, Koichi Goto, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 11, 2023
Expert consensus to optimize the management of older adult patients with advanced EGFR-mutated non-small cell lung cancerErnest Nadal, Martín Oré-Arce, Jordi Remon, et al.
Internet Interventions|June 5, 2023
An eHealth ecosystem for stepped and early psychosocial care in advanced lung cancer: Rationale and protocol for a randomized control trialCristian Ochoa-Arnedo, Alejandra Arizu-Onassis, Joan C Medina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2016
A Novel Epigenetic Signature for Early Diagnosis in Lung CancerAngel Diaz-Lagares, Jesus Mendez-Gonzalez, David Hervas, et al.
Clinical Kidney Journal|August 12, 2024
Urinary soluble PD-1 as a biomarker of checkpoint inhibitor-induced acute tubulointerstitial nephritisFrancisco Gomez-Preciado, Laura Martinez-Valenzuela, Paula Anton-Pampols, et al.
Lung Cancer (Amsterdam, Netherlands)|August 9, 2025
Single-cell RNA-sequencing as a potential approach for studying intratumor heterogeneity in pleural mesotheliomaAnia Alay, Raúl Marín, Elisabet Aliagas, et al.
Oncotarget|July 1, 2016
Genomic similarity between gastroesophageal junction and esophageal Barrett's adenocarcinomasDaysha Ferrer-Torres, Derek J Nancarrow, Rork Kuick, et al.
British Journal of Cancer|January 31, 2018
Geriatric assessment may help decision-making in elderly patients with inoperable, locally advanced non-small-cell lung cancerMaite Antonio, Juana Saldaña, Jennifer Linares, et al.
Plos One|March 24, 2015
Elevated levels of the complement activation product C4d in bronchial fluids for the diagnosis of lung cancerDaniel Ajona, Cristina Razquin, Maria Dolores Pastor, et al.
Pageof 17